ETR:CE2

CropEnergies (CE2) Stock Price, News & Analysis

€11.50
0.00 (0.00%)
(As of 02/29/2024)
Today's Range
€11.14
€11.52
50-Day Range
€11.20
€11.58
52-Week Range
€6.75
€11.84
Volume
23,283 shs
Average Volume
N/A
Market Capitalization
$1.00 billion
P/E Ratio
15.33
Dividend Yield
5.22%
Price Target
N/A
CE2 stock logo

About CropEnergies Stock (ETR:CE2)

CropEnergies AG manufactures and distributes bioethanol, and other biofuels and related products produced from grain or other agricultural raw materials in Germany and internationally. The company also produces and sells protein food and animal feed products, including ProtiGrain, a protein animal feed for ruminants, pigs, poultry and pets as well as in aquaculture; wheat gluten for food and animal feed; distillers dried grains with solubles for animal feed; and ProtiWanze, a liquid animal feed for cattle, pet food, and pigs. In addition, it offers liquefied carbon dioxide; and produces neutral alcohol for beverage, food, cosmetics, and pharmaceutical industries, as well as for industrial applications; and biobased chemicals. The company was incorporated in 2006 and is headquartered in Mannheim, Germany. CropEnergies AG operates as a subsidiary of Südzucker AG.

CE2 Stock Price History

CE2 Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
CropEnergies AG CE2
Tsingtao: Video shows Chinese beer worker urinating into tank
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
CropEnergies AG (CE2.BE)
CropEnergies AG (CE2.DE)
See More Headlines
Receive CE2 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CropEnergies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
483
Year Founded
N/A

Profitability

Net Income
$65.67 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.25 billion
Cash Flow
€0.50 per share
Book Value
€8.86 per share

Miscellaneous

Free Float
N/A
Market Cap
$1.00 billion
Optionable
Not Optionable
Beta
0.70
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Dr. Fritz Georg von Graevenitz (Age 47)
    CEO & Member of Executive Board
    Comp: $251.89k
  • Mr. Jurgen Bottcher (Age 62)
    Chief Operating Officer & Member of Executive Board
    Comp: $264.93k
  • Ms. Heike Baumbach
    CFO & Member of Executive Board

CE2 Stock Analysis - Frequently Asked Questions

How have CE2 shares performed in 2024?

CropEnergies' stock was trading at €11.50 at the beginning of the year. Since then, CE2 stock has increased by 0.0% and is now trading at €11.50.
View the best growth stocks for 2024 here
.

Is CropEnergies a good dividend stock?

CropEnergies (ETR:CE2) pays an annual dividend of €0.60 per share and currently has a dividend yield of 5.21%. CE2 has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 80.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

What other stocks do shareholders of CropEnergies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CropEnergies investors own include AbbVie (ABBV), Abiomed (ABMD), Catalent (CTLT), Dynavax Technologies (DVAX), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX) and ARCA biopharma (ABIO).

This page (ETR:CE2) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners